CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design Left main coronary artery compression in pulmonary hypertension Chronic thromboembolic pulmonary hypertension Sotatercept for the Treatment of Pulmonary Arterial Hypertension Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension
|<<... 2 3 4 5 6 7 8 ...>>|

Expert Opinion2019 Feb 11;12(3):285-288.

JOURNAL：JACC Cardiovasc Interv. Article Link

Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?

Dimopoulos K, Ernst S, McCabe C et al. Keywords: ablation; diastolic dysfunction; pre- and post-capillary pulmonary hypertension; pulmonary artery denervation

LINK

Please click on the "Article Link" on top right to get further access to this Editorial Comment.
>CBS CBS 2019

> CBS 2019 REGISTRATION

> CBS 2019 PROGRAM

> CBS 2019 CALL FOR SCIENCE

> CBS 2019 SPOTLIGHTS

 CBSMD

> CBSMD WEBSITE REGISTRATION

> EDUCATION CENTER

> RECOMMANDED PAPER

> TOP 10 RESEARCH PAPER

> PRE-READING

CBS 2019 CBS 2019 FACULTY Education Resource CBSMD Scientific Library
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top